APA aipamena

Gallardo, A., Lerma, E., Escuin, D., Tibau, A., Muñoz, J., Ojeda, B., . . . Peiró, G. (2012). Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Nature Publishing Group.

Chicago Style aipamena

Gallardo, A., et al. Increased Signalling of EGFR and IGF1R, and Deregulation of PTEN/PI3K/Akt Pathway Are Related With Trastuzumab Resistance in HER2 Breast Carcinomas. Nature Publishing Group, 2012.

MLA aipamena

Gallardo, A., et al. Increased Signalling of EGFR and IGF1R, and Deregulation of PTEN/PI3K/Akt Pathway Are Related With Trastuzumab Resistance in HER2 Breast Carcinomas. Nature Publishing Group, 2012.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.